Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Gelatinase B/matrix metalloproteinase-9 is a phase-specific effector molecule, independent from Fas, in experimental autoimmune encephalomyelitis
Authors
Keywords
-
Journal
PLoS One
Volume 13, Issue 10, Pages e0197944
Publisher
Public Library of Science (PLoS)
Online
2018-10-02
DOI
10.1371/journal.pone.0197944
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chemokine isoforms and processing in inflammation and immunity
- (2017) Paul Proost et al. JOURNAL OF AUTOIMMUNITY
- Trial of Minocycline in a Clinically Isolated Syndrome of Multiple Sclerosis
- (2017) Luanne M. Metz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of gelatinase B/MMP-9 does not attenuate colitis in murine models of inflammatory bowel disease
- (2017) Magali de Bruyn et al. Nature Communications
- Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
- (2016) Simone M. Brändle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Imaging matrix metalloproteinase activity in multiple sclerosis as a specific marker of leukocyte penetration of the blood-brain barrier
- (2016) H. Gerwien et al. Science Translational Medicine
- Microbiomic and Posttranslational Modifications as Preludes to Autoimmune Diseases
- (2016) Ghislain Opdenakker et al. TRENDS IN MOLECULAR MEDICINE
- Passenger Mutations Confound Interpretation of All Genetically Modified Congenic Mice
- (2015) Tom Vanden Berghe et al. IMMUNITY
- An optimized method to process mouse CNS to simultaneously analyze neural cells and leukocytes by flow cytometry
- (2015) Laurine Legroux et al. JOURNAL OF NEUROSCIENCE METHODS
- Focal MMP-2 and MMP-9 Activity at the Blood-Brain Barrier Promotes Chemokine-Induced Leukocyte Migration
- (2015) Jian Song et al. Cell Reports
- Minocycline: far beyond an antibiotic
- (2013) N Garrido-Mesa et al. BRITISH JOURNAL OF PHARMACOLOGY
- Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9): The next decade
- (2013) Jennifer Vandooren et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Cytokine profile in relapsing-remitting multiple sclerosis patients and the association between progression and activity of the disease
- (2013) ANA PAULA KALLAUR et al. Molecular Medicine Reports
- Zymography methods for visualizing hydrolytic enzymes
- (2013) Jennifer Vandooren et al. NATURE METHODS
- Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes
- (2012) Nele Berghmans et al. Journal of Neuroinflammation
- Multiple Sclerosis: Pathogenesis and Treatment
- (2011) Ingrid Loma et al. Current Neuropharmacology
- Deficiency of gelatinase B/MMP-9 aggravates lpr-induced lymphoproliferation and lupus-like systemic autoimmune disease
- (2011) Bénédicte Cauwe et al. JOURNAL OF AUTOIMMUNITY
- Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination
- (2011) Kerstin Berer et al. NATURE
- Intracellular substrate cleavage: a novel dimension in the biochemistry, biology and pathology of matrix metalloproteinases
- (2010) Bénédicte Cauwe et al. CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
- (2010) Jeffrey A. Cohen et al. NEW ENGLAND JOURNAL OF MEDICINE
- Avoiding spam in the proteolytic internet: Future strategies for anti-metastatic MMP inhibition
- (2009) Achim Krüger et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Multidimensional degradomics identifies systemic autoantigens and intracellular matrix proteins as novel gelatinase B/MMP-9 substrates
- (2009) Bénédicte Cauwe et al. Integrative Biology
- Matrix Metalloproteinase Proteolysis of the Myelin Basic Protein Isoforms Is a Source of Immunogenic Peptides in Autoimmune Multiple Sclerosis
- (2009) Sergey A. Shiryaev et al. PLoS One
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now